[HTML][HTML] Incidence of stroke in people with diabetes compared to those without diabetes: A systematic review
T Kvitkina, M Narres, H Claessen… - Experimental and …, 2023 - thieme-connect.com
Background One of the goals of the St. Vincent Declaration was to reduce serious
complications of diabetes, including strokes. However, it remains uncertain whether this goal …
complications of diabetes, including strokes. However, it remains uncertain whether this goal …
Percutaneous Left Atrial Appendage Closure Among Patients With Diabetes (Insights from a National Database)
Atrial fibrillation is a major risk factor for stroke. Left atrial appendage closure (LAAC) has
emerged as an alternative to anticoagulation for patients with high risk of bleeding. Diabetes …
emerged as an alternative to anticoagulation for patients with high risk of bleeding. Diabetes …
Diabetes and smoking: the burden of evidence
S Aggarwal, D Khandelwal, D Dutta, S Kalra… - The Diabetes Textbook …, 2023 - Springer
Smoking is a well-known risk factor for many chronic diseases, including cardiovascular
diseases and various malignancies. Smoking is associated with higher insulin resistance …
diseases and various malignancies. Smoking is associated with higher insulin resistance …
All-cause, cardiovascular and respiratory mortality in people with type 2 diabetes and chronic obstructive pulmonary disease (COPD) in England: A cohort study using …
AS Raslan, JK Quint, S Cook - International Journal of Chronic …, 2023 - Taylor & Francis
Background Type 2 diabetes (T2D) and chronic obstructive pulmonary disease (COPD) are
common non-communicable diseases. Both have an inflammatory nature and similar risk …
common non-communicable diseases. Both have an inflammatory nature and similar risk …
Diabetes Mellitus in Women: A Call to Action
JO Edah - Tropical Journal of Medical Research, 2023 - tjmr.org.ng
Diabetes mellitus (DM) poses a huge burden on individuals and the health system globally.
Its effects on individuals lead to morbidity and mortality arising from cardiovascular diseases …
Its effects on individuals lead to morbidity and mortality arising from cardiovascular diseases …
Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study
T Mita, N Katakami, H Yoshii, T Onuma, H Kaneto… - Scientific Reports, 2023 - nature.com
We previously reported in the study of preventive effects of alogliptin on diabetic
atherosclerosis (SPEAD-A) that alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor …
atherosclerosis (SPEAD-A) that alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor …